Vicarious Surgical Shuts Down: Surgical Robotics Startup Folds After $300M and a SPAC

Vicarious Surgical, a US developer of surgical robots, is officially winding down, The Robot Report reported in July 2026. Over its lifetime the company raised about $300M, and most of that came not from traditional venture rounds but from a 2021 merger with a SPAC.

How much money did the startup raise?

Over the years, Vicarious Surgical raised roughly $300M, and the lion's share of that capital came from its 2021 public listing via a SPAC, according to The Robot Report. The company was founded in 2014 in Waltham, Massachusetts; its early investors reportedly included prominent figures such as Bill Gates.

• About $300M — total capital raised
• 2021 — went public through a merger with a SPAC (NYSE: RBOT)
• 2014 — company founded in Waltham, Massachusetts
• A single-port robot for minimally invasive surgery through one incision
• July 2026 — closure announced

Why the SPAC didn't save the company

The 2021 SPAC merger gave Vicarious Surgical hundreds of millions of dollars, but it did not solve the core problem: the startup never had a commercially available product. 2021 was the peak of the SPAC boom, when dozens of unprofitable tech companies went public through blank-check holding companies, bypassing the scrutiny of a traditional IPO. For hardware companies, that route proved especially risky.

Building a surgical robot means years of engineering and a long road to FDA clearance, not a fast software release cycle. Vicarious Surgical was developing a single-port system with miniature "humanlike" manipulators inserted through a single incision. A product like that requires clinical trials and regulatory certification, and throughout that time the company spent its capital without any revenue. By 2026 the money ran out before the robot reached the operating room.

Vicarious

Surgical raised about $300M, most of it in the 2021 SPAC merger.

> — according to The Robot Report

What this means

The shutdown of Vicarious Surgical is another sign of the hangover from the 2021 SPAC boom: capital raised on hype is no substitute for a finished product and regulatory approval. For robotics hardware with a long development cycle, the lesson is especially harsh — the money runs out faster than the technology matures enough for the market.

Frequently asked questions

How much money did Vicarious Surgical raise?

According to The Robot Report, the company raised about $300M over its lifetime. Most of that came not through venture rounds but through a 2021 merger with a SPAC.

How did Vicarious Surgical go public?

The company went public in 2021 not through a traditional IPO but through a merger with a SPAC — a blank-check holding company created to take private companies public quickly. Its shares traded on the NYSE under the ticker RBOT.